Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SeerSEER -1.43%54 EV-to-FCF is 0.60 as of Jul. 23, 2026, which is 49% below its 10-year median of 1.18. GuruFocus rates SEER with a GF Score™ of 54/100 and a GF Value™ of $2.21 (Fairly Valued). The stock has 6 warning signs investors should review. Among 337 Biotechnology companies, Seer ranks better than 82.49% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Seer's Enterprise Value is $-29.83 Mil.
Seer's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-49.88 Mil. Therefore, Seer's EV-to-FCF for today is 0.60.
The historical rank and industry rank for Seer's EV-to-FCF or its related term are showing as below:
SEER'
s EV-to-FCF Range Over the Past 10 Years
Min: -53.46 Med: 1.18 Max: 2.99
Current: 0.6
During the past 8 years, the highest EV-to-FCF of Seer was 2.99. The lowest was -53.46. And the median was 1.18.
SEER's EV-to-FCF is ranked better than 82.49% of 337
companies
in the Biotechnology industry
Industry Median: 15.15
vs SEER: 0.60
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-23), Seer's stock price is $2.07.
Seer's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.240. Therefore, Seer's PE Ratio (TTM) for today is At Loss.
Seer (NAS:SEER) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Seer's share price for today is $2.07.
Seer's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.240.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Seer EV-to-FCF Related Terms
Seer EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Seer's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Seer's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Seer EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Seer's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Seer's EV-to-FCF falls into.
Seer's current Enterprise Value is $-29.83 Mil.
Seer's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-49.88 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Seer (SEER) has a EV-to-FCF of 0.60 as of Jul. 23, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Seer and its competitors. This is 49% below median its historical median of 1.18. According to the industry distribution chart, Seer ranks #59 out of 337 companies in the Biotechnology industry, placing it in the top 17.5%.
Is Seer's EV-to-FCF too high?
Seer's current EV-to-FCF of 0.60 is 49% below median its 10-year median of 1.18. The Biotechnology industry median EV-to-FCF is 15.15. Seer's value of 0.60 is 96% below this industry median. Based on the distribution chart, Seer ranks #59 out of 337 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Seer has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Seer's EV-to-FCF compare to CSBR and RLYB?
According to the Biotechnology industry distribution chart, Seer ranks #59 out of 337 companies for EV-to-FCF. This places Seer in the top 18% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 15.15. Seer's value of 0.60 is 96% below this benchmark. While the company's 10-year median is 1.18 vs. the industry median of 15.15, Seer has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 15.15, based on 337 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Seer's current EV-to-FCF of 0.60 is 96% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Seer and its competitors. For the Biotechnology industry, the median EV-to-FCF is 15.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Seer's current EV-to-FCF is 0.60, which is 49% below median its own 10-year median of 1.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seer stock overvalued right now?
Based on GuruFocus' analysis, Seer (SEER) is currently considered Fairly Valued. The stock's GF Value™ is $2.21, compared to a current price of $2.07 — trading 6.3% below its estimated fair value. The current EV-to-FCF is 0.60, which is 49% below median its 10-year median of 1.18 and 96% below the Biotechnology industry median of 15.15. Seer's overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Seer (SEER), the current EV-to-FCF is 0.60 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Seer (SEER) Overvalued in 2026?
Based on GuruFocus' analysis, Seer stock appears to be undervalued.
The current stock price of $2.07 is trading 6.3% below its estimated GF Value™ of $2.21.
GuruFocus considers Seer to be Fairly Valued.
Key valuation signals for SEER:
EV-to-FCF: 0.60 (49% below median its 10-year median of 1.18)
GF Value™: $2.21 vs. price of $2.07 (6.3% below fair value)
Industry Position: 96% below the Biotechnology median (#59 of 337)
No single metric tells the full story. See the SEER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
54GF Score
Get the complete analysis for SEER
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SEER has been successfully added to your 
